Jimmy Panetta (D-CA)

STAND Against Emerging Opioids Act

H.R. 3520 · House bill Crime and Law Enforcement

A Democratic bill with 2 Republican cosponsors · See all 2 cosponsors

Last activity — Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

In committee

Introduced and handed to a committee in the chamber it started in.

The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.

Its path through Congress

  1. Introduced
  2. In Committee

What this bill would do

This bill, known as the "STAND Against Emerging Opioids Act," seeks to amend the Controlled Substances Act. It specifically proposes to move tianeptine into the schedule III category. This classification would include tianeptine's analogues, salts, isomers, and salts of isomers. The change is intended to address emerging opioids. The new regulations would take effect 90 days after the act is enacted.

Yes

  • Scored +5

    Does this do more about addiction and overdose deaths?

    The bill aims to combat emerging opioid trends by scheduling tianeptine as a controlled substance.

  • Scored +3

    Does this give the federal government more power?

    The bill expands federal control by amending the Controlled Substances Act to schedule a new substance.

The opposite

No question was scored the opposite.